WT (WT)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company exhibits robust fundamental economics characterized by a high-quality earnings profile driven primarily by superior profitability rather than operational leverage or balance sheet expansion. A DuPont decomposition reveals that the 26.4% return on equity is overwhelmingly supported by a commanding net margin of 22.1%, while asset turnover remains modest at 0.33x and financial leverage sits at 3.66x, indicating earnings power stems from pricing strength rather than aggressive capital structuring. This operational efficiency is corroborated by strong quality metrics: a Piotroski F-Score of 6/9 signals solid financial health with positive trends in profitability and leverage management, while a Beneish M-Score of -2.28 suggests the absence of earnings manipulation risks often associated with inflated valuations.
Valuation analysis presents a divergence between current market pricing and intrinsic value estimates derived from discounted cash flow modeling. Although specific historical multiples are not provided for direct comparison, the DCF model implies a fair value of $33, suggesting that if this figure diverges significantly from the current trading price, the market may be mispricing future growth expectations relative to the company's ability to generate free cash flows at its current trajectory. The 15.4% year-over-year revenue growth supports an implied growth rate necessary for such a valuation, yet investors must assess whether the stock currently trades above or below this $33 anchor point to determine if premiums are being paid for sustainable expansion.
Risk assessment is tempered by mixed signals regarding insider sentiment and potential style factors. While the Piotroski score indicates financial resilience, the net selling of approximately $501,932 in insider transactions over the last 90 days introduces a cautionary note that may reflect management's view on near-term liquidity or valuation levels rather than long-term fundamentals. Without sector-specific beta data to contextualize volatility or Fama-French alpha figures to gauge style exposure, the risk-reward profile hinges largely on whether the gap between current market price and the $33 fair value can withstand potential insider-driven headwinds while maintaining its high-margin operational model.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8% | 10% | 12% |
|---|---|---|---|
| 2% | $41 | $29 | $22 |
| 3% | $49 | $33 | $24 |
| 4% | $60 | $38 | $27 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $33 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like SLYG or SPSM, the fund manager is mechanically forced to buy or sell WT shares regardless of WT's individual fundamentals. We estimate $33M of passive capital is structurally linked to WT through 4 tracked ETFs. Passive flows have a limited but growing influence on WT's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 4 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in WT to visualize passive redemption contagion across ETFs and collateral stocks.
If WT (WT) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies JPMorgan Chase & Co. (JPM) as the most exposed collateral stock, sharing 1 ETFs with WT. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 4 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
WT Ownership Dynamics
ETFs with Highest WT Exposure
Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
WT Capital Efficiency
How efficiently does WT convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
WT converts 81% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 53,642 | $19.49 | $1.0M |
| 2026-05-13 | 302,991 | $18.72 | $5.7M |
| 2026-05-11 | 11 | $19.10 | $210.1 |
| 2026-05-08 | 8,923 | $18.72 | $167,038.56 |
| 2026-05-07 | 5,824 | $19.06 | $111,005.44 |
| 2026-04-20 | 10,000 | $17.46 | $174,600 |
| 2026-04-14 | 54,200 | $16.38 | $887,796 |
| 2026-04-13 | 537,165 | $15.84 | $8.5M |
| 2026-04-10 | 216,778 | $15.85 | $3.4M |
| 2026-04-09 | 13,720 | $15.56 | $213,483.2 |
| 2026-04-08 | 9,622 | $15.10 | $145,292.2 |
| 2026-04-07 | 128,450 | $14.94 | $1.9M |
| 2026-04-06 | 61,013 | $14.45 | $881,637.85 |
| 2026-04-01 | 300 | $14.56 | $4,368 |
| 2026-03-31 | 13,412 | $13.92 | $186,695.04 |
| 2026-03-27 | 60,272 | $14.55 | $876,957.6 |
| 2026-03-20 | 34,803 | $13.86 | $482,369.58 |
| 2026-03-19 | 84,282 | $14.26 | $1.2M |
| 2026-03-18 | 675 | $15.05 | $10,158.75 |
| 2026-03-17 | 9,637 | $14.84 | $143,013.08 |
| 2026-03-16 | 966 | $15.26 | $14,741.16 |
| 2026-03-12 | 2,588 | $15.67 | $40,553.96 |
| 2026-03-09 | 165 | $16.62 | $2,742.3 |
| 2026-03-03 | 42,050 | $17.52 | $736,716 |
| 2026-03-02 | 6,185 | $17.11 | $105,825.35 |
| 2026-02-27 | 77,412 | $17.37 | $1.3M |
| 2026-02-26 | 37,533 | $17.31 | $649,696.23 |
| 2026-02-25 | 59,494 | $16.69 | $992,954.86 |
| 2026-02-23 | 91,087 | $16.38 | $1.5M |
| 2026-02-20 | 3,528 | $16.51 | $58,247.28 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare WT to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.